Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
901 W Wellington Ave
Chicago, IL 60657Phone+1 773-296-7089Fax+1 773-296-7731
Education & Training
- University Hospitals2002
- Summa Health System/NEOMEDResidency, Internal Medicine, 1996 - 1999
- Northeast Ohio Medical UniversityClass of 1996
Certifications & Licensure
- IL State Medical License 2002 - 2026
- OH State Medical License 1997 - 2016
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 234 citationsA phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.Ignacio Duran, J. Kortmansky, D. Singh, H. Hirte, Walter Kocha
British Journal of Cancer. 2006-11-06 - 79 citationsMulticenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaJ. A. Ajani, F. C. Lee, D. A. Singh, D. G. Haller, Heinz-Josef Lenz
Journal of Clinical Oncology. 2006-02-01 - 48 citationsExtended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.Heinz Joseph Lenz, F. C. Lee, Daniel G. Haller, D. A. Singh, Al B. Benson
Cancer. 2007-01-01
Press Mentions
- First Edition: June 18, 2021June 18th, 2021
Professional Memberships
- Member
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: